{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:28:02Z","timestamp":1740634082800,"version":"3.38.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,26]]},"DOI":"10.7759\/cureus.79705","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T18:14:51Z","timestamp":1740593691000},"source":"Crossref","is-referenced-by-count":0,"title":["The Use of Freestyle Libre Glucose Monitoring System and Diabetes Treatment Progression in Type 2 Diabetes Mellitus: A Retrospective Cohort Study in Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Raed A","family":"Aljohani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan N","family":"Altaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa A","family":"Kofi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"IDF Diabetes Atlas","author":"Magliano D","year":"2021","unstructured":"Magliano D, Boyko EJ. IDF Diabetes Atlas. International Diabetes Federation, Brussels; 2021."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0244-4","article-title":"Prevalence of metabolic syndrome in Saudi Arabia - a cross sectional study","volume":"18","author":"Al-Rubeaan K","year":"2018","unstructured":"Al-Rubeaan K, Bawazeer N, Al Farsi Y, et al.. Prevalence of metabolic syndrome in Saudi Arabia - a cross sectional study. BMC Endocr Disord. 2018, 18:16. 10.1186\/s12902-018-0244-4","journal-title":"BMC Endocr Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S010","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes-2021","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2021. Diabetes Care. 2021, 44:S125-S150. 10.2337\/dc21-S010","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1581","article-title":"Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring","volume":"41","author":"Bergenstal RM","year":"2018","unstructured":"Bergenstal RM, Beck RW, Close KL, et al.. Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018, 41:2275-2280. 10.2337\/dc18-1581","journal-title":"Diabetes Care"},{"key":"ref5","unstructured":"Freestyle Libre 3 system. Abbott. (2025). Accessed. February 8, 2025: https:\/\/www.freestyle.abbott\/us-en\/products\/freestyle-libre-3.html."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2009.0077","article-title":"Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring","volume":"11","author":"Rodbard D","year":"2009","unstructured":"Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg SK. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther. 2009, 11:717-723. 10.1089\/dia.2009.0077","journal-title":"Diabetes Technol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-016-0223-6","article-title":"Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial","volume":"8","author":"Haak T","year":"2017","unstructured":"Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017, 8:55-73. 10.1007\/s13300-016-0223-6","journal-title":"Diabetes Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0846","article-title":"Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes","volume":"32","author":"Bode B","year":"2009","unstructured":"Bode B, Beck RW, Xing D, et al.. Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care. 2009, 32:2047-2049. 10.2337\/dc09-0846","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2855","article-title":"Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial","volume":"167","author":"Beck RW","year":"2017","unstructured":"Beck RW, Riddlesworth TD, Ruedy K, et al.. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017, 167:365-374. 10.7326\/M16-2855","journal-title":"Ann Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13585","article-title":"Continuous glucose monitoring in pregnant women with Type 1 diabetes: benefits for mothers, using pumps or pens, and their babies","volume":"35","author":"Feig DS","year":"2018","unstructured":"Feig DS, Murphy HR. Continuous glucose monitoring in pregnant women with Type 1 diabetes: benefits for mothers, using pumps or pens, and their babies. Diabet Med. 2018, 35:430-435. 10.1111\/dme.13585","journal-title":"Diabet Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4140\/TCP.n.2021.556","article-title":"The use of continuous glucose monitoring in older people with type 2 diabetes","volume":"36","author":"Rao H","year":"2021","unstructured":"Rao H, Fakourfar N, Sun C, Lewis J. The use of continuous glucose monitoring in older people with type 2 diabetes. Sr Care Pharm. 2021, 36:556-567. 10.4140\/TCP.n.2021.556","journal-title":"Sr Care Pharm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2040038.019","article-title":"Current status of continuous glucose monitoring among Korean children and adolescents with type 1 diabetes mellitus","volume":"25","author":"Kim JH","year":"2020","unstructured":"Kim JH. Current status of continuous glucose monitoring among Korean children and adolescents with type 1 diabetes mellitus. Ann Pediatr Endocrinol Metab. 2020, 25:145-151. 10.6065\/apem.2040038.019","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30167-5","article-title":"Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials","volume":"5","author":"Weisman A","year":"2017","unstructured":"Weisman A, Bai JW, Cardinezet M, Kramer CK, Perkins BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol. 2017, 5:501-512. 10.1016\/S2213-8587(17)30167-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0303","article-title":"Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry","volume":"37","author":"Wong JC","year":"2014","unstructured":"Wong JC, Foster NC, Maahs DM, et al.. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014, 37:2702-2709. 10.2337\/dc14-0303","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0455","article-title":"Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control","volume":"20","author":"Riddlesworth TD","year":"2018","unstructured":"Riddlesworth TD, Beck RW, Gal RL, Connor CG, Bergenstal RM, Lee S, Willi SM. Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control. Diabetes Technol Ther. 2018, 20:314-316. 10.1089\/dia.2017.0455","journal-title":"Diabetes Technol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30297-6","article-title":"Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial","volume":"391","author":"Heinemann L","year":"2018","unstructured":"Heinemann L, Freckmann G, Ehrmann D, Faber-Heinemann G, Guerra S, Waldenmaier D, Hermanns N. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018, 391:1367-1377. 10.1016\/S0140-6736(18)30297-6","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1438","article-title":"Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes","volume":"35","author":"Vigersky RA","year":"2012","unstructured":"Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2012, 35:32-38. 10.2337\/dc11-1438","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15025","article-title":"Use of the FreeStyle Libre system and diabetes treatment progression in T2DM: results from a retrospective cohort study using a Canadian private payer claims database","volume":"25","author":"Harris SB","year":"2023","unstructured":"Harris SB, Levrat-Guillen F. Use of the FreeStyle Libre system and diabetes treatment progression in T2DM: results from a retrospective cohort study using a Canadian private payer claims database. Diabetes Obes Metab. 2023, 25:1704-1713. 10.1111\/dom.15025","journal-title":"Diabetes Obes Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0021","article-title":"How can we realize the clinical benefits of continuous glucose monitoring?","volume":"19","author":"Ajjan RA","year":"2017","unstructured":"Ajjan RA. How can we realize the clinical benefits of continuous glucose monitoring?. Diabetes Technol Ther. 2017, 19:S27-S36. 10.1089\/dia.2017.0021","journal-title":"Diabetes Technol Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi SE","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, et al.. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015, 38:140-149. 10.2337\/dc14-2441","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0493","article-title":"Continuous glucose monitor metrics are associated with emergency department visits and hospitalizations for hypoglycemia and hyperglycemia, but have low predictive value","volume":"26","author":"Gilliam LK","year":"2024","unstructured":"Gilliam LK, Parker MM, Moffet HH, Lee AK, Karter AJ. Continuous glucose monitor metrics are associated with emergency department visits and hospitalizations for hypoglycemia and hyperglycemia, but have low predictive value. Diabetes Technol Ther. 2024, 26:298-306. 10.1089\/dia.2023.0493","journal-title":"Diabetes Technol Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-2073","article-title":"Comparison of the FreeStyle Libre Pro Flash continuous glucose monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with Basal-Bolus insulin regimen","volume":"43","author":"Galindo RJ","year":"2020","unstructured":"Galindo RJ, Migdal AL, Davis GM, et al.. Comparison of the FreeStyle Libre Pro Flash continuous glucose monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with Basal-Bolus insulin regimen. Diabetes Care. 2020, 43:2730-2735. 10.2337\/dc19-2073","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.02.027","article-title":"Impact of the FreeStyle Libre flash glucose monitoring system on diabetes- self-management practices and glycemic control among patients with type 2 diabetes in Saudi Arabia: a prospective study","volume":"15","author":"Al Hayek A","year":"2021","unstructured":"Al Hayek A, Robert AA, Al Dawish M. Impact of the FreeStyle Libre flash glucose monitoring system on diabetes- self-management practices and glycemic control among patients with type 2 diabetes in Saudi Arabia: a prospective study. Diabetes Metab Syndr. 2021, 15:557-563. 10.1016\/j.dsx.2021.02.027","journal-title":"Diabetes Metab Syndr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4236\/ijcm.2022.138027","article-title":"The impact of the FreeStyle LibreTM flash glucose monitoring system on glycemic control in patients with diabetes; observational multicenter 15-months study","volume":"13","author":"Alsifri S","year":"2022","unstructured":"Alsifri S, Almalki A, Alsifri S, et al.. The impact of the FreeStyle LibreTM flash glucose monitoring system on glycemic control in patients with diabetes; observational multicenter 15-months study. Int J Clin Med. 2022, 13:391-404. 10.4236\/ijcm.2022.138027","journal-title":"Int J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342427-the-use-of-freestyle-libre-glucose-monitoring-system-and-diabetes-treatment-progression-in-type-2-diabetes-mellitus-a-retrospective-cohort-study-in-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T18:14:53Z","timestamp":1740593693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342427-the-use-of-freestyle-libre-glucose-monitoring-system-and-diabetes-treatment-progression-in-type-2-diabetes-mellitus-a-retrospective-cohort-study-in-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.79705","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}